TNSN05067A1 - Acetyl 2-hydroxy- 1,3 diaminoalkanes - Google Patents

Acetyl 2-hydroxy- 1,3 diaminoalkanes

Info

Publication number
TNSN05067A1
TNSN05067A1 TNP2005000067A TNSN05067A TNSN05067A1 TN SN05067 A1 TNSN05067 A1 TN SN05067A1 TN P2005000067 A TNP2005000067 A TN P2005000067A TN SN05067 A TNSN05067 A TN SN05067A TN SN05067 A1 TNSN05067 A1 TN SN05067A1
Authority
TN
Tunisia
Prior art keywords
diaminoalkanes
acetyl
hydroxy
compounds
disclosed
Prior art date
Application number
TNP2005000067A
Inventor
Michel Maillard
Eric T Baldwin
James T Beck
Robert Hughes
Varghese John
Shon R Pulley
Ruth Tenbrink
Original Assignee
Elan Pharm Inc
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/028503 external-priority patent/WO2004024081A2/en
Application filed by Elan Pharm Inc, Pharmacia & Upjohn Co Llc filed Critical Elan Pharm Inc
Publication of TNSN05067A1 publication Critical patent/TNSN05067A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

DISCLOSED ARE COMPOUNDS OF THE FORMULA : (I) WHERE VARIABLES Z, X, R15, R2, R3, AND Rc ARE DEFINED HEREIN. COMPOUNDS DISCLOSED HEREIN ARE INHIBITORS OF THE BETA-SECRETASE ENZYME AND ARE THEREFORE USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISEASES CHARACTERIZED BY DEPOSITION OF A BETA PEPTIDE IN A MAMMAL.
TNP2005000067A 2002-09-10 2005-03-08 Acetyl 2-hydroxy- 1,3 diaminoalkanes TNSN05067A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40945302P 2002-09-10 2002-09-10
PCT/US2003/028503 WO2004024081A2 (en) 2002-09-10 2003-09-10 Acetyl 2-hydroxy-1,3 diaminoalkanes

Publications (1)

Publication Number Publication Date
TNSN05067A1 true TNSN05067A1 (en) 2007-05-14

Family

ID=35353421

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2005000067A TNSN05067A1 (en) 2002-09-10 2005-03-08 Acetyl 2-hydroxy- 1,3 diaminoalkanes

Country Status (5)

Country Link
CN (1) CN100384824C (en)
AP (1) AP2005003247A0 (en)
CR (1) CR7720A (en)
TN (1) TNSN05067A1 (en)
ZA (1) ZA200501991B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010030538A1 (en) * 2010-06-25 2011-12-29 Bayer Schering Pharma Aktiengesellschaft 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments
DE102011087987A1 (en) * 2011-12-08 2013-06-13 Bayer Intellectual Property Gmbh 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments
CN109790079B (en) * 2016-07-29 2022-06-03 香港科技大学 C (sp) of organozinc reagents and heterocyclic (pseudo) halides3)-C(sp2) Cross-coupling reaction
EP3490607A4 (en) * 2016-07-29 2020-04-08 Sunovion Pharmaceuticals Inc. Compounds and compositions and uses thereof
JP7191085B2 (en) 2017-08-02 2022-12-16 サノビオン ファーマシューティカルズ インク Isochroman compounds and uses thereof
CN113189089B (en) * 2021-03-19 2022-05-17 四川轻化工大学 Ozone detection reagent and preparation device and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482947A (en) * 1990-11-19 1996-01-09 Talley; John J. Retroviral protease inhibitors
AU749281B2 (en) * 1997-02-04 2002-06-20 Regents Of The University Of California, The Nanomolar, non-peptide inhibitors of cathepsin D

Also Published As

Publication number Publication date
CN1694870A (en) 2005-11-09
AP2005003247A0 (en) 2005-03-31
CN100384824C (en) 2008-04-30
CR7720A (en) 2005-07-14
ZA200501991B (en) 2006-01-25

Similar Documents

Publication Publication Date Title
WO2004024081A3 (en) Acetyl 2-hydroxy-1,3 diaminoalkanes
WO2003103653A8 (en) Methods of treating alzheimer's disease using aryl alkanoic acid amides
WO2005095326A3 (en) 2-amino- and 2-thio-substituted 1,3-diaminopropanes
MXPA04000328A (en) Statine derivatives for the treatment of alzheimer's disease.
WO2002076440A3 (en) Methods of treating alzheimer's disease with piperidin derivates
BR0214035A (en) Compound
MXPA05011150A (en) (HETERO) ARYLAMIDE 2-HYDROXY-3-DIAMINOALKANES FOR USE IN THE TREATMENT OF ALZHEIMERaCOES DISEASE.
NZ516599A (en) 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
WO2004022523A3 (en) 1, 3-diamino-2-hydroxypropane prodrug derivatives
NO20032801L (en) Thiazole derivatives for the treatment of PPAR-related disorders
MXPA04003245A (en) Hydroxypropylamines.
TW200505418A (en) Phenacyl 2-hydroxy-3-diaminoalkanes
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
RS53704A (en) Alpha-(n-sulphonamido)acetamide derivatives as betha- amyloid inhibitors
MXPA05002420A (en) Thiazole compounds for the treatment of neurodegenerative disorders.
CA2379747A1 (en) Novel succinate derivative compounds useful as cysteine protease inhibitors
TW200505828A (en) Substituted ureas and carbamates useful in the treatment of alzheimer's disease
MXPA04002785A (en) Substituted amines for the treatment of alzheimer's disease.
TNSN05067A1 (en) Acetyl 2-hydroxy- 1,3 diaminoalkanes
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
MXPA03011466A (en) Macrocycles useful in the treatment of alzheimer's disease.
BR0213138A (en) Methods of treating or preventing alzheimer's disease and a disease distinguished by beta-amyloid deposition in the brain, treating a patient who has, or preventing a patient from contracting a disease or condition, producing a beta-secretase complex and inhibit beta-amyloid plaque production in an animal, composition and use of a compound
AU2002356991A1 (en) Amino acid derivatives useful for the treatment of alzheimer's disease
MXPA03011399A (en) Methods of treating alzheimer's disease.
MXPA03011502A (en) Substituted aminoalcohols useful in treatment of alzheimer's disease.